Femme et Homme
- | Pays :
- Indonesia
- | Organes : -
- | Spécialités : -
Extrait
This multi-center observational study will evaluate the use and efficacy of RoActemra/Actemra (tocilizumab) in patients with moderate to severe rheumatoid arthritis. Eligible patients initiated on RoActemra/Actemra treatment according to the licensed label will be followed for 6 months.
Critère d'inclusion
- Rheumatoid Arthritis